期刊文献+

沙格列汀联合胰岛素对2型糖尿病血糖控制及生活质量的影响

Effects of Saxagliptin Combined with Insulin on Blood Glucose Control and Quality of Life in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的探讨沙格列汀联合胰岛素对2型糖尿病患者血糖控制及生活质量的影响。方法选取周口市疾病预防控制中心专科病医院2型糖尿病患者64例,按随机数字表法分组,各32例,对照组予以胰岛素治疗,观察组于此基础上联合沙格列汀治疗。对比两组治疗效果、治疗前后空腹血糖(FPG)水平、餐后2 h血糖(2 h PG)水平、生活质量评分及不良反应。结果观察组总有效率96.88%高于对照组75.00%(P<0.05);观察组FPG、2 h PG水平低于对照组(P<0.05),生活质量评分高于对照组(P<0.05);观察组不良反应发生率3.13%与对照组比较无明显差异(P>0.05)。结论沙格列汀联合胰岛素治疗2型糖尿病患者,血糖控制效果显著,能提高患者生活质量,且安全性高。 Objective To investigate the effect of saxagliptin combined with insulin on blood glucose control and quality of life in type 2 diabetic patients. Methods 64 patients with type 2 diabetes were selected from the specialist hospital of Zhoukou Municipal Center for Disease Control and Prevention. Randomized data were divided into 32 groups. The control group was treated with insulin,and the observation group was treated with saxagliptin. The treatment effects,fasting plasma glucose( FPG),postprandial 2 h blood glucose( 2 h PG) levels,quality of life scores,and adverse reactions were compared between the two groups. Results The total effective rate was 96. 88 % in the observation group and 75. 00 % in the control group( P〈 0. 05).The FPG and 2 h PG levels in the observation group were lower than those in the control group( P〈 0. 05),and the quality of life score was higher than that in the control group( P〈 0. 05). The incidence of adverse reactions in the observation group was 3. 13 % compared with the control group( P〈 0. 05). Conclusion The combination of saxagliptin and insulin in the treatment of type 2 diabetes has significant effect on blood glucose control,can improve the quality of life of patients,and has high safety.
作者 袁慧芳 YUAN Hui-fang(Department of Endocrinology,Specialized Disease Hospital,Zhoukou Center for Disease Control and Prevention,Zhoukou 466000 China)
出处 《内蒙古医学杂志》 2018年第5期513-515,共3页 Inner Mongolia Medical Journal
关键词 沙格列汀 胰岛素 2型糖尿病 生活质量 saxagliptin insulin type 2 diabetes quality of life
  • 相关文献

参考文献5

二级参考文献34

  • 1Ceriello A, Ihnat MA. Glycaemic variability: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med, 2010,27 : 862-867.
  • 2Hsu CW. Glycemic control in critically ill patients. World J Crit Care Med,2012,1:31 39.
  • 3Egi M,Bellomo R,Stachowski E,et al. Variability of blood glu- cose concentration and short-term mortality in critically ill pa- tients. Anesthesiology, 2006,105 : 244 252.
  • 4Hirsch IB, Brownlee M. Should minimal blood glucose variabili ty become the gold standard control? J Diabetes Complica tions, 2005,19 : 178 181.
  • 5Vilsboll T, Rosenstock J, Yki-Jfirvinen H, et al. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obes Metab,2010,12:167-177.
  • 6He YL, Foteinos G, Neelakantham S, et al. Differential effects of vildagliptin and glimepiride onglucose fluctuations in patients with type 2 diabetesmellitus assessed using continuous glucose monitoring. Diabetes Obes Metab, 2013,15 : 1111-1119.
  • 7Gfike B. Islet cell function: alpha and beta cell-partners towards normoglycacmia [J]. Int J Clin Pract Suppl,2008, (159) :2-7.
  • 8Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardi- ovascular outcomes in type 2 diabetes mellitus[ J]. N Engl J Med, 2013,369 (14) : 1317-1326.
  • 9Scirica BM, Bhatt DL, Braunwald E, et al. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in pa- tients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI)53 study[J]. Am Heart J,2011,162(5) :818-825.
  • 10Williams-Herman D, Xu L, Teng R, et al. Effect of initial combina- tion therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes [ J]. Diabetes 0bes Metab, 2012,14 ( 1 ) :67-76.

共引文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部